Literature DB >> 22855515

Effects of storage on vancomycin and daptomycin MIC in susceptible blood isolates of methicillin-resistant Staphylococcus aureus.

Franziska Ludwig1, Becky Edwards, Timothy Lawes, Ian M Gould.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22855515      PMCID： PMC3457431          DOI： 10.1128/JCM.01158-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  35 in total

Review 1.  The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.

Authors:  S J van Hal; T P Lodise; D L Paterson
Journal:  Clin Infect Dis       Date:  2012-02-02       Impact factor: 9.079

2.  Loss of the mecA gene during storage of methicillin-resistant Staphylococcus aureus strains.

Authors:  Arjanne van Griethuysen; Inge van Loo; Alex van Belkum; Christina Vandenbroucke-Grauls; Wim Wannet; Peter van Keulen; Jan Kluytmans
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

3.  Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006.

Authors:  Robert L Holmes; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2007-11-26       Impact factor: 5.191

4.  Vancomycin MIC creep in MRSA blood culture isolates from Germany: a regional problem?

Authors:  J Kehrmann; M Kaase; F Szabados; S G Gatermann; J Buer; P-M Rath; J Steinmann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-13       Impact factor: 3.267

Review 5.  Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.

Authors:  K Hiramatsu
Journal:  Lancet Infect Dis       Date:  2001-10       Impact factor: 25.071

6.  Daptomycin non-susceptibility in vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous-VISA (hVISA): implications for therapy after vancomycin treatment failure.

Authors:  Peter G Kelley; Wei Gao; Peter B Ward; Benjamin P Howden
Journal:  J Antimicrob Chemother       Date:  2011-03-02       Impact factor: 5.790

7.  Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006.

Authors:  Heather J Adam; Lisa Louie; Christine Watt; Denise Gravel; Elizabeth Bryce; Mark Loeb; Anne Matlow; Allison McGeer; Michael R Mulvey; Andrew E Simor
Journal:  Antimicrob Agents Chemother       Date:  2009-11-30       Impact factor: 5.191

8.  Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus.

Authors:  Helio S Sader; Paul R Rhomberg; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2009-04-27       Impact factor: 5.191

9.  Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus.

Authors:  Longzhu Cui; Xiaoxue Ma; Katsuhiro Sato; Keiko Okuma; Fred C Tenover; Elsa M Mamizuka; Curtis G Gemmell; Mi-Na Kim; Marie-Cecile Ploy; N El-Solh; Vivian Ferraz; Keiichi Hiramatsu
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

10.  Vancomycin MICs did not creep in Staphylococcus aureus isolates from 2002 to 2006 in a setting with low vancomycin usage.

Authors:  Juan-Ignacio Alós; Ana García-Cañas; Paloma García-Hierro; Francisco Rodríguez-Salvanés
Journal:  J Antimicrob Chemother       Date:  2008-06-13       Impact factor: 5.790
View more
  15 in total

1.  Predictors of Adverse Outcomes in Children With Staphylococcus aureus Bacteremia.

Authors:  Ganesh Kumarachandran; Jennifer Kristie Johnson; Debbie-Ann Shirley; Eileen Graffunder; Emily L Heil
Journal:  J Pediatr Pharmacol Ther       Date:  2017 May-Jun

2.  Influence of vancomycin minimum inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus left-sided infective endocarditis treated with antistaphylococcal β-lactam antibiotics: a prospective cohort study by the International Collaboration on Endocarditis.

Authors:  J M Pericàs; J A Messina; C Garcia-de-la-Mària; L Park; B K Sharma-Kuinkel; F Marco; D Wray; Z A Kanafani; M Carugati; E Durante-Mangoni; P Tattevin; V H Chu; A Moreno; V G Fowler; J M Miró
Journal:  Clin Microbiol Infect       Date:  2017-02-01       Impact factor: 8.067

3.  Effects of Frozen Storage on Detection of Intermediate Vancomycin Susceptibility and Heteroresistance in Methicillin-Resistant Staphylococcus aureus Blood Isolates.

Authors:  K Riederer; S Iyer; S Shemes; V Dejaeghere; M Sharma; S Szpunar; R Khatib
Journal:  J Clin Microbiol       Date:  2015-04-29       Impact factor: 5.948

4.  Impact of Time to Appropriate Therapy on Mortality in Patients with Vancomycin-Intermediate Staphylococcus aureus Infection.

Authors:  Jason P Burnham; C A Burnham; David K Warren; Marin H Kollef
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

5.  Evaluation of telavancin susceptibility in isolates of Staphylococcus aureus with reduced susceptibility to vancomycin.

Authors:  Allison R McMullen; William Lainhart; Meghan A Wallace; Angela Shupe; Carey-Ann D Burnham
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-08-24       Impact factor: 3.267

6.  Precision of vancomycin and daptomycin MICs for methicillin-resistant Staphylococcus aureus and effect of subculture and storage.

Authors:  Carmen L Charlton; Janet A Hindler; John Turnidge; Romney M Humphries
Journal:  J Clin Microbiol       Date:  2014-08-20       Impact factor: 5.948

7.  Reproducible measurement of vancomycin MICs within the susceptible range in Staphylococcus aureus by a broth microdilution method with a "quasi-continuum" gradient of antibiotic concentrations.

Authors:  R Falcón; E M Mateo; A Talaya; E Giménez; V Vinuesa; M Á Clari; D Navarro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-25       Impact factor: 3.267

8.  Heterogeneous vancomycin-intermediate among methicillin resistant Staphylococcus aureus.

Authors:  C N Chaudhari; K Tandel; N Grover; S Sen; P Bhatt; A K Sahni; A K Praharaj
Journal:  Med J Armed Forces India       Date:  2014-06-07

9.  Impact of Vancomycin MIC on Treatment Outcomes in Invasive Staphylococcus aureus Infections.

Authors:  Kyoung-Ho Song; Moonsuk Kim; Chung Jong Kim; Jeong Eun Cho; Yun Jung Choi; Jeong Su Park; Soyeon Ahn; Hee-Chang Jang; Kyung-Hwa Park; Sook-In Jung; Nara Yoon; Dong-Min Kim; Jeong-Hwan Hwang; Chang Seop Lee; Jae Hoon Lee; Yee Gyung Kwak; Eu Suk Kim; Seong Yeon Park; Yoonseon Park; Kkot Sil Lee; Yeong-Seon Lee; Hong Bin Kim
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

10.  Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients.

Authors:  Guillermo Cuervo; Mariana Camoez; Evelyn Shaw; María Ángeles Dominguez; Oriol Gasch; Belén Padilla; Vicente Pintado; Benito Almirante; José Molina; Francisco López-Medrano; Enrique Ruiz de Gopegui; José A Martinez; Elena Bereciartua; Fernando Rodriguez-Lopez; Carlos Fernandez-Mazarrasa; Miguel Ángel Goenaga; Natividad Benito; Jesús Rodriguez-Baño; Elena Espejo; Miquel Pujol
Journal:  BMC Infect Dis       Date:  2015-10-30       Impact factor: 3.090
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.